Dormarie E. Rivera-Rodriguez

Dormarie E. Rivera-Rodriguez

Auto-generated profile, based on publicly available information

Dormarie E. Rivera-Rodriguez

Department of Microbiology and Immunology, Emory University School of Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 January 2025 in Science Immunology
Verified
Journal Article
Closed access
CECody Elkins
Cody Elkins
CYChengyu Ye
Chengyu Ye
PSPulavendran Sivasami
Pulavendran Sivasami
RMRoy Mulpur
Roy Mulpur
PDPamela P. Diaz-Saldana
Pamela P. Diaz-Saldana
CLChaoran Li
Chaoran Li
Regulatory T cells (T regs ) accumulate in the visceral adipose tissue (VAT) to maintain systemic metabolic homeostasis but decline during obesity. Here, we explored the metabolic pathways controlling the homeostasis, composition, and function of VAT T regs under normal and high-fat diet feeding conditions. We found that cholesterol metabolism was specifically up-regulated in ST2 hi VAT T reg subsets. T reg -specific deletion of Srebf2 , the master regulator of cholesterol homeostasis, selectively reduced ST2 hi VAT T regs , increasing VAT inflammation and insulin resistance. Single-cell RNA/T cell receptor (TCR) sequencing revealed a specific loss and reduced clonal expansion of ST2 hi VAT T reg subsets after Srebf2 deletion. Srebf2 -mediated cholesterol homeostasis potentiated strong TCR signaling, which preferentially promoted ST2 hi VAT T reg accumulation. However, long-term high-fat diet feeding disrupted VAT T reg cholesterol homeostasis and impaired clonal expansion of the ST2 hi subset. Restoring T reg cholesterol homeostasis rescued VAT T reg accumulation in obese mice, suggesting that modulation of cholesterol homeostasis could be a promising strategy for T reg -targeted therapies in obesity-associated metabolic diseases.

19 November 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
DRDormarie E. Rivera-Rodriguez
Dormarie E. Rivera-Rodriguez
CBChayse Busby
Chayse Busby
ALAbigail Lee
Abigail Lee
ELEva Li
Eva Li
IGIsabelle Gracien
Isabelle Gracien
DWDavid Weiss
David Weiss
Lactobacilli are prevalent members of the microbiota in the intestinal and reproductive tracts of humans and other species. They are commonly used in probiotics due to their beneficial effects on human health, including their association with protection from numerous chronic diseases. In addition, these microbes are often prescribed to maintain their presence in the host during antibiotic therapy, as well as to treat diarrhea caused by antibiotics. Despite many studies examining the beneficial effects of lactobacilli, less is known about how they survive during antibiotic treatment, and in particular, whether they exhibit heteroresistance, a phenotype in which only a minor subpopulation of resistant cells coexists with a majority susceptible population. Here, we tested representative Lactobacillus species for heteroresistance to a broad panel of relevant antibiotics. The results demonstrate that Lactobacillus strains, including those isolated from human feces, can exhibit heteroresistance to relevant antibiotics from distinct classes, and are often heteroresistant to fluoroquinolones. In particular, heteroresistance to fluoroquinolones was even observed in Lactobacillus rhamnosus GG, a widely used probiotic. These findings significantly impact our understanding of how lactobacilli, including strains isolated from human samples, can survive antibiotic treatment, and how individual probiotic strains may be selected for use during antibiotic therapy to promote their survival and maximize their benefits. IMPORTANCE: Commensal bacteria, such as Lactobacillus species, are widely used for their beneficial effects on gastrointestinal health and their potential to help restore the gut microbial community after antibiotic use. However, the antibiotic resistance profiles of these beneficial bacteria have received limited attention despite their relevance to probiotic use. Heteroresistance is a phenomenon in which a small subpopulation of resistant bacteria within an otherwise susceptible community survives antibiotic exposure, but it is often undetected, underappreciated, and has largely not been investigated among commensal bacteria. Our study provides a characterization of heteroresistance across distinct Lactobacillus species and a panel of antibiotics, revealing that heteroresistance is far more widespread than previously appreciated, especially to fluoroquinolones. These findings suggest probiotic strains could be selected that would survive concurrent antibiotic therapy and thus highlight that more comprehensive resistance profiling of probiotic bacteria may yield benefits to patients.